| Literature DB >> 35460723 |
Marie T Kumerow1, Juan L Rodriguez2, Shifan Dai3, Katherine Kolor4, Melissa Rotunno5, Lucy A Peipins6.
Abstract
The collection and evaluation of family health history in a clinical setting presents an opportunity to discuss cancer risk, tailor cancer screening recommendations, and identify people with an increased risk of carrying a pathogenic variant who may benefit from referral to genetic counseling and testing. National recommendations for breast and colorectal cancer screening indicate that men and women who have a first-degree relative affected with these types of cancers may benefit from talking to a healthcare provider about starting screening at an earlier age and other options for cancer prevention. The prevalence of reporting a first-degree relative who had cancer was assessed among adult respondents of the 2015 National Health Interview Survey who had never had cancer themselves (n = 27,999). We found 35.6% of adults reported having at least one first-degree relative with cancer at any site. Significant differences in reporting a family history of cancer were observed by sex, age, race/ethnicity, educational attainment, and census region. Nearly 5% of women under age 50 and 2.5% of adults under age 50 had at least one first-degree relative with breast cancer or colorectal cancer, respectively. We estimated that 5.8% of women had a family history of breast or ovarian cancer that may indicate increased genetic risk. A third of U.S. adults who have never had cancer report a family history of cancer in a first-degree relative. This finding underscores the importance of using family history to inform discussions about cancer risk and screening options between healthcare providers and their patients. Published by Elsevier Inc.Entities:
Keywords: Family history; Hereditary breast and ovarian cancer syndrome; Hereditary neoplastic syndromes; Neoplasm; Public health surveillance
Mesh:
Year: 2022 PMID: 35460723 PMCID: PMC9162122 DOI: 10.1016/j.ypmed.2022.107062
Source DB: PubMed Journal: Prev Med ISSN: 0091-7435 Impact factor: 4.637